Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Chu

Showing results (1-10 of 211) with videos related to

Pageof 22
Sort By:
Clinical Colorectal Cancer|July 16, 2010
Integration of targeted therapies with cytotoxic chemotherapy in the treatment of colorectal cancerEdward Chu
JAMA Network Open|March 21, 2025
Rethinking a "Successful" AblationEdward Chu
Clinical Colorectal Cancer|June 23, 2004
Bevacizumab targeted therapy: validation of angiogenesis as a key target for advanced colorectal cancerEdward Chu
Clinical Colorectal Cancer|June 3, 2005
Making sense out of antisense thymidylate synthaseEdward Chu
Clinical Colorectal Cancer|March 4, 2006
Clinical colorectal cancer: new advances in screeningEdward Chu
Clinical Colorectal Cancer|December 13, 2005
Introduction: Emerging therapies with epidermal growth factor receptor-targeted agents in colorectal cancerEdward Chu
Clinical Colorectal Cancer|September 2, 2006
The potential role of gene profiling in the management of early-stage colon cancerEdward Chu
Clinical Colorectal Cancer|September 21, 2004
Dihydopyrimidine dehydrogenase: a critical molecular biomarker for 5-Fluorouracil toxicityEdward Chu
Clinical Colorectal Cancer|September 17, 2008
Sequential versus combination therapy: where are we?Edward Chu
Clinical Colorectal Cancer|August 8, 2007
The role of a drug holiday: revisitedEdward Chu
Pageof 22

Showing results (1-10 of 211) with videos related to

Sort By:
Pageof 22
Clinical Colorectal Cancer|July 16, 2010
Integration of targeted therapies with cytotoxic chemotherapy in the treatment of colorectal cancerEdward Chu
JAMA Network Open|March 21, 2025
Rethinking a "Successful" AblationEdward Chu
Clinical Colorectal Cancer|June 23, 2004
Bevacizumab targeted therapy: validation of angiogenesis as a key target for advanced colorectal cancerEdward Chu
Clinical Colorectal Cancer|June 3, 2005
Making sense out of antisense thymidylate synthaseEdward Chu
Clinical Colorectal Cancer|March 4, 2006
Clinical colorectal cancer: new advances in screeningEdward Chu
Clinical Colorectal Cancer|December 13, 2005
Introduction: Emerging therapies with epidermal growth factor receptor-targeted agents in colorectal cancerEdward Chu
Clinical Colorectal Cancer|September 2, 2006
The potential role of gene profiling in the management of early-stage colon cancerEdward Chu
Clinical Colorectal Cancer|September 21, 2004
Dihydopyrimidine dehydrogenase: a critical molecular biomarker for 5-Fluorouracil toxicityEdward Chu
Clinical Colorectal Cancer|September 17, 2008
Sequential versus combination therapy: where are we?Edward Chu
Clinical Colorectal Cancer|August 8, 2007
The role of a drug holiday: revisitedEdward Chu
Pageof 22